NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE47871 Query DataSets for GSE47871
Status Public on Jun 13, 2013
Title Antitumoral activity of acadesine and rituximab in MCL
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Acadesine is a nucleoside analogue with known antileukemic effects in different neoplasms. We investigated the activity of acadesine ne exerts a cytotoxic effect in MCL and synergizes with rituximab supporting clinical examination of this strategy for MCL patients
We used microarrays to detail the gene expression changes in acadesine-, rituximab- and combination-treated tumors.
 
Overall design Global RNA expression in tumors treated with acadesine, rituximab and the combination in a xenograft model of MCL (Jeko-1). Tumors were collected 18 days after the initiation of the treatments.
 
Contributor(s) Montraveta A, Colomer D
Citation(s) 24519895
Submission date Jun 12, 2013
Last update date Mar 21, 2019
Contact name DOLORS COLOMER
E-mail(s) dcolomer@clinic.cat
Phone 34 660775688
Organization name IDIBAPS-HOSPITAL CLINIC
Street address VILLARROEL 170
City BARCELONA
ZIP/Postal code 08036
Country Spain
 
Platforms (1)
GPL13667 [HG-U219] Affymetrix Human Genome U219 Array
Samples (12)
GSM1161343 Control, biological rep1
GSM1161344 Control, biological rep2
GSM1161345 Control, biological rep3
Relations
BioProject PRJNA208230

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE47871_RAW.tar 26.6 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap